Posts by Nicholas Alan Clayton

Latest

SPACCircle Acquisition Corp. (SCQCU) Prices $100M IPO

SPACCircle Acquisition Corp. (NASDAQ:SCQCU) announced the pricing of its $100 million IPO and its units are expected to begin trading on the Nasdaq under the symbol "SCQCU" on Tuesday, October 27, 2026. More

Nicholas Alan Clayton·Oct 26

Amanat (AMAN) to Combine with Corxel US in $228M Deal

Amanat (NASDAQ:AMAN) has entered into a definitive agreement to combine with biotech firm Corxel Pharmaceuticals at an enterprise value of $228 million. Corxel is developing an oral GLP-1 weight-loss drug as well as other potential treatments. More

Nicholas Alan Clayton·Oct 26

Morning SPAC News Roundup: October 26, 2026

With just one week left in October, the month has currently represented a slowdown in SPAC IPOs, with just four teams pricing their vehicles since October 1. More

Nicholas Alan Clayton·Oct 26

Morning SPAC News Roundup: October 23, 2026

A relatively placid week in SPACs comes to an end with new information on a variety of pending deals, including filings that provide more texture on Newbury Street II's (NASDAQ:NTWO) PIPE and investor presentations for both a pending definitive agreement and even a non-binding letter of intent. More

Nicholas Alan Clayton·Oct 23

Morning SPAC News Roundup: October 22, 2026

After a week that has been relatively light on major macroeconomic news, this morning is set to see new unemployment numbers and a Fed survey, which could move the needle. More

Nicholas Alan Clayton·Oct 22

APEX Tech (TRAD) to Combine with Korai Flix in $3.5Bn Deal

APEX Tech (NYSE:TRAD) has entered into a definitive agreement to combine with South Korean film studio Korai Flix at a $3.5 billion pre-money equity value. Korai Flix has launched an online content platform that provides AI-generated short films and allows users to produce their own interactive content with AI avatars. More

Nicholas Alan Clayton·Oct 21

Morning SPAC News Roundup: October 21, 2026

APEX Tech (NYSE:TRAD) has brought a fresh business combination to the table as it scratches two itches SPACs have recently had with both film production studios and AI technology applications. More

Nicholas Alan Clayton·Oct 21

Morning SPAC News Roundup: October 20, 2026

AI jitters have hit the market again with a significant drop to several digital infrastructure stocks and there are already signs that banks have begun to hedge. More

Nicholas Alan Clayton·Oct 20

TCGX (TCGX) to Combine with TriGemX Bio in $403M Deal

TCGX I (NASDAQ:TCGX) has signed a definitive agreement to combine with drug developer TriGemX Bio at a pro forma enterprise value of $402.8 million. New York-based TriGemX Bio is developing a drug candidate for the treatment of acute migraines that is currently in Phase III trials. More

Nicholas Alan Clayton·Oct 19

Morning SPAC News Roundup: October 19, 2026

The third week of October is set to host three SPAC shareholder votes and could include as many or more IPOs with AEI CapForce II (NASDAQ:AEIBU), SPACCircle (NASDAQ:SCQCU), Allarity (NASDAQ:ALLNU), and Harbour Island I (NASDAQ:HRIAU) all lined up to attempt to price their offerings this week. More

Nicholas Alan Clayton·Oct 19